• 8 April 2014

    FDA approves GE Healthcare’s Q.Clear technology

    GE Healthcare has obtained 510(k) approval from the US Food and Drug Administration (FDA) for its Q.Clear technology that can provide up to two times improvement in both quantitative accuracy...

  • 3 April 2014

    Luoxis’ RedoxSYS diagnostic system gets CE Mark approval

    Ampio Pharmaceuticals subsidiary Luoxis Diagnostics has obtained CE Mark approval for its RedoxSYS, a point-of-care diagnostic instrument with accompanying disposable sensors that rapidly measure and report unique oxidative stress parameters...